Ginsenoside Ameliorates Cognitive Dysfunction in Type 2 Diabetic Goto-Kakizaki Rats

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2018 Jun 11

PMID 29886506

Citations 8

Authors

Zhiyan Tian

Ning Ren

Jinghua Wang

Danhong Zhang

Yuying Zhou

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Ginsenoside is the major bioactive component of ginseng, which has been proven to be a neuroprotective drug. The aim of this study was to evaluate the therapeutic effect of ginsenoside in a diabetic Goto-Kakizaki (GK) rat model. MATERIAL AND METHODS Twenty GK rats were randomly divided into a diabetic model (DM) group (n=10) and a ginsenoside + DM group (n=10); Wistar rats with the same age and body weight were used as the control (CON) group (n=10). Food and water intake, body weight, and blood fasting plasma glucose were measured. The Morris water maze test was used to detect learning and memory functions of the rats. Superoxide dismutase (SOD), malondialdehyde (MDA), and inflammatory cytokines (TNF-α, IL-1β, and IL-6) in the hippocampus were analyzed after ginsenoside treatment. RESULTS The blood glucose, body weight, Morris correlation index, SOD, MDA, and other test results were increased in the diabetic rats. Ginsenoside ameliorated diabetic cognitive decline. CONCLUSIONS The possible mechanism was related to inhibiting brain oxidative/nitrosative damage and affecting the expression of the cytokines IL-1β, IL-6, and TNF-α.

Citing Articles

Altered pattern separation in Goto-Kakizaki rats.

Damphousse C, Medeiros J, Micks N, Marrone D Curr Res Neurobiol. 2023; 4:100082.

PMID: 37397815 PMC: 10313866. DOI: 10.1016/j.crneur.2023.100082.

Functional Integration of Adult-Generated Neurons in Diabetic Goto-Kakizaki Rats.

Damphousse C, Medeiros J, Marrone D Front Behav Neurosci. 2021; 15:734359.

PMID: 34675787 PMC: 8523851. DOI: 10.3389/fnbeh.2021.734359.

The Use of Natural Compounds as a Strategy to Counteract Oxidative Stress in Animal Models of Diabetes Mellitus.

Salazar-Garcia M, Corona J Int J Mol Sci. 2021; 22(13).

PMID: 34209800 PMC: 8268811. DOI: 10.3390/ijms22137009.

Prehabilitative exercise hastens recovery from isoflurane in diabetic and non-diabetic rats.

Sinon C, Ottensmeyer A, Slone A, Li D, Allen R, Pardue M Neurosci Lett. 2021; 751:135808.

PMID: 33705936 PMC: 8601585. DOI: 10.1016/j.neulet.2021.135808.

Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.

Yang S, Hsu C, Chou W, Fang J, Chuang S Molecules. 2020; 25(23).

PMID: 33287318 PMC: 7731446. DOI: 10.3390/molecules25235713.

References

Saczynski J, Jonsdottir M, Garcia M, Jonsson P, Peila R, Eiriksdottir G . Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility--Reykjavik study. Am J Epidemiol. 2008; 168(10):1132-9. PMC: 2727243. DOI: 10.1093/aje/kwn228. View

Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, Del Canizo-Gomez F . Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?. World J Diabetes. 2014; 5(4):444-70. PMC: 4127581. DOI: 10.4239/wjd.v5.i4.444. View

Chatterjee S, Peters S, Woodward M, Mejia Arango S, Batty G, Beckett N . Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia. Diabetes Care. 2015; 39(2):300-7. PMC: 4722942. DOI: 10.2337/dc15-1588. View

Qi L, Wang C, Yuan C . American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol. 2010; 80(7):947-54. DOI: 10.1016/j.bcp.2010.06.023. View

Arvanitakis Z, Wilson R, Bienias J, Evans D, Bennett D . Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004; 61(5):661-6. DOI: 10.1001/archneur.61.5.661. View

Arvanitakis Z, Wilson R, Li Y, Aggarwal N, Bennett D . Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care. 2006; 29(3):560-5. DOI: 10.2337/diacare.29.03.06.dc05-1901. View

Luchsinger J, Reitz C, Patel B, Tang M, Manly J, Mayeux R . Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007; 64(4):570-5. DOI: 10.1001/archneur.64.4.570. View

Katon W, Lyles C, Parker M, Karter A, Huang E, Whitmer R . Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry. 2011; 69(4):410-7. PMC: 3558525. DOI: 10.1001/archgenpsychiatry.2011.154. View

Liu M, Zhang J . Effects of ginsenoside Rb1 and Rg1 on synaptosomal free calcium level, ATPase and calmodulin in rat hippocampus. Chin Med J (Engl). 1995; 108(7):544-7. View

10.

Luchsinger J, Tang M, Stern Y, Shea S, Mayeux R . Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001; 154(7):635-41. DOI: 10.1093/aje/154.7.635. View

11.

Schnaider Beeri M, Goldbourt U, Silverman J, Noy S, Schmeidler J, Ravona-Springer R . Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004; 63(10):1902-7. DOI: 10.1212/01.wnl.0000144278.79488.dd. View

12.

Dey L, Xie J, Wang A, Wu J, Maleckar S, Yuan C . Anti-hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine. 2003; 10(6-7):600-5. DOI: 10.1078/094471103322331908. View

13.

Christensen L . Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res. 2008; 55:1-99. DOI: 10.1016/S1043-4526(08)00401-4. View

14.

Xie J, Zhou Y, Dey L, Attele A, Wu J, Gu M . Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine. 2002; 9(3):254-8. DOI: 10.1078/0944-7113-00106. View

15.

Vorhees C, Williams M . Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2007; 1(2):848-58. PMC: 2895266. DOI: 10.1038/nprot.2006.116. View

16.

Wang C, Aung H, Ni M, Wu J, Tong R, Wicks S . Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 2007; 73(7):669-74. PMC: 2657361. DOI: 10.1055/s-2007-981524. View

17.

Attele A, Zhou Y, Xie J, Wu J, Zhang L, Dey L . Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002; 51(6):1851-8. DOI: 10.2337/diabetes.51.6.1851. View

18.

Qi L, Wang C, Yuan C . Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry. 2011; 72(8):689-99. PMC: 3103855. DOI: 10.1016/j.phytochem.2011.02.012. View

19.

Fontbonne A, Berr C, Ducimetiere P, Alperovitch A . Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care. 2001; 24(2):366-70. DOI: 10.2337/diacare.24.2.366. View

20.

Biessels G, Staekenborg S, Brunner E, Brayne C, Scheltens P . Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2005; 5(1):64-74. DOI: 10.1016/S1474-4422(05)70284-2. View